|
Jan 15
|
Merck Animal Health's Fourth Veterinary Wellbeing Study Indicates Progress in Addressing Mental Health Challenges Among Veterinary Teams
|
|
Jan 13
|
Insiders At Merck Sold US$10m In Stock, Alluding To Potential Weakness
|
|
Jan 12
|
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy as Treatment for Patients With FIGO 2014 Stage III-IVA Cervical Cancer
|
|
Jan 12
|
UPDATE 2-Merck's Keytruda combo gets FDA nod for expanded use in cervical cancer
|
|
Jan 10
|
JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market
|
|
Jan 10
|
5 questions facing pharma in 2024
|
|
Jan 9
|
Company News for Jan 9, 2024
|
|
Jan 9
|
Are Robust Financials Driving The Recent Rally In Merck & Co., Inc.'s (NYSE:MRK) Stock?
|
|
Dec 22
|
12 Best Undervalued Stocks to Buy According to Reddit
|
|
Dec 22
|
Patritumab Deruxtecan Granted Priority Review in the U.S. for Certain Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
|
|
Dec 21
|
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Receive Public Listing for Patients with Advanced Endometrial Carcinoma (EC) that is not MSI-H or dMMR
|
|
Dec 20
|
Merck Provides U.S. Regulatory Update on Gefapixant
|
|
Dec 20
|
FDA Accepts Merck's (MRK) BLA for 21-Valent Pneumococcal Jab
|
|
Dec 20
|
Merck to Participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference
|
|
Dec 19
|
13 Most Promising Growth Stocks According to Analysts
|
|
Dec 19
|
Merck (MRK) Gets EU Nod for Expanded Use in Gastric Cancer
|
|
Dec 19
|
Merck gets FDA decision date for new pneumococcal vaccine
|
|
Dec 19
|
FDA Grants Priority Review to Merck’s New Biologics License Application for V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed to Protect Adults
|
|
Dec 10
|
12 Dow Stocks Billionaires Like The Most
|
|
Dec 10
|
12 Healthcare Stocks Billionaires Like the Most
|